The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.
Antitumor effects of citrinin in an animal model of Sarcoma 180 via cytogenetic mechanisms
Corresponding Author(s) : Javad Sharifi-Rad
javad.sharifirad@gmail.com
Cellular and Molecular Biology,
Vol. 66 No. 4: Medicinal plants and natural products
Abstract
Citrinin (CIT) is a cytotoxic, hepatotoxic, nephrotoxic and cardiotoxic metabolite obtained from Penicillium citrinum, that has been increasingly searched as an anticancer drug candidate. In this study, we assessed the antitumor effects of citrinin, using cytogenetic biomarkers for genotoxicity in Sarcoma 180 (S-180) ascitic fluid cells of mice. Citrinin, extracted from P. citrinum acetonitrile extract, was characterized by LC-MS. Cytotoxic assessment was done through using comet (alkaline version) and micronucleus assays. In S-180 cells, CI50 of CIT was 3.77 μg/mL, while at 12.5 and 100 μg/mL, CIT was as cytotoxic as doxorubicin (2 μg/mL). At 0.5, 1.0 and 2.0 μg/mL, it induced genotoxicity and mutagenicity in S-180 cells, especially at 2 μg/mL, triggering oxidative damage similar to hydrogen peroxide (10 mM). The antitumor effects were evidenced by a marked increase in S-180 cells apoptosis and necrosis due to clastogenic and/or aneugenic cytogenetic effects (micronucleus formation), as well as by induction of nucleoplasm bridges and nuclear buds, culminating in S-180 apoptosis and necrosis. CIT has potential as drug candidate for antitumor purposesbyinvolving cytogenetic mechanisms.
Keywords
Sarcoma 180
Citrinin
Cytogenetic
Apoptosis.
Filho, J. W. G. de O., dos Santos Andrade, T. de J. A., de Lima, R. M. T., dos Reis, A. C., Hameed, A., Santos, J. V. de O., Afzal, M. I., de Menezes, A.-A. P. M., de Alencar, M. V. O. B., Silva, D. H. S., Dias, A. C. S., Ferreira, J. R. de O., Islam, M. T., Ferreira, P. M. P., Salehi, B., Qamar, M., Umer, M., Imran, M., Sharifi-Rad, J., Martins, N., de Castro e Sousa, J. M., & Melo Cavalcante, A. A. de C. (2020). Antitumor effects of citrinin in an animal model of Sarcoma 180 via cytogenetic mechanisms. Cellular and Molecular Biology, 66(4), 120–126. https://doi.org/10.14715/cmb/2020.66.4.16
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
